Milestone Pharmaceuticals Priced Its Public Offering Of 16.7M Shares At $1.50/Share And Pre-funded Warrants To Purchase 3.3M Shares At $1.49/Pre-funded Warrant, With Gross Proceeds Of Approximately $30M
Milestone Pharmicals將其公開發行1670萬股股票定價爲每股1.50美元，預先籌集資金的認股權證將以1.49美元/預先注資的認股權證購買330萬股股票，總收益約爲3000萬美元